The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
According to the latest report by IMARC Group, titled “ Urology Robotic Surgery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forec ast 2023-2028
” the global urology robotic surgery market reached a strong growth in 2022.
Urology robotic surgery is a minimally invasive treatment that includes miniaturized computercontrolled manipulators and surgical instruments with a video camera and artificial sensing solutions. These devices are placed in small punctures instead of large incisions by various robotic consoles under the supervision of healthcare professionals to reach distant and critical spaces and view highly magnified and clear three-dimensional (3D) pictures of the area to be operated. It encompasses robotic machines, navigation systems, simulators, planners, and other crucial accessories as standard equipment types. Urology robotic surgery offers accurate motions and increased magnification, maximizes productivity, ensures peer collaborations during treatment procedures, and minimizes recovery time, blood loss, and post-surgical complications. Apart from this, it reduces scarring, pain, discomfort, and the risk of infection ensures shorter hospitalization and provides better clinical outcomes. As a result, urology robotic surgeries are extensively utilized in hospitals and clinics for prostatectomy, cystectomy, nephrectomy, and pyeloplasty surgical procedures.
Request Free Sample Report:
https://www.imarcgroup.com/urology-robotic-surgery-market/requestsample
The increasing prevalence of kidney or urinary tract diseases represents one of the key factors driving the market growth. The increasing geriatric population, which is susceptible to such ailments, is also contributing to the market growth. In line with this, the rising demand for minimally invasive assisted surgeries for knee and hip replacements, due to their multiple benefits over traditional surgical procedures, is acting as another growth-inducing factor. Additionally, the rising need for automated surgical tools that significantly reduce the chances of human errors is driving the market toward growth. Moreover, the integration of robot-assisted flexible endoscopes with the system that enables healthcare practitioners to access and treat complex anatomies and enhance precision in diagnostic proceedings is favoring the market growth. Furthermore, the advent of the software-enforced remote center of motion (RCM) and modular robotic surgical systems with complex motion control capability is impelling the market growth. Apart from this, the ongoing research and development (R&D) activities to manufacture urology surgical robots with enhanced efficacy and the fueling number of product diversification for surgical interventions are creating a positive outlook for the market. Other factors, such as increasing healthcare budgets and improving healthcare infrastructure, are driving the market growth.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
Market Summary:
Component Insights:
• Robotic Surgery Systems
• Instruments and Accessories
• Services
Application Insights:
• Robotic Prostatectomy
• Robotic Cystectomy
• Robotic Pyeloplasty
• Robotic Nephrectomy
• Others
Regional Insights:
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
Note: We are updating our reports, If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report.
Competitive Landscape with Key Players: Johnson & Johnson
Medtronic plc
Stryker Corporation
Surgical Science Sweden AB
Kindly note that this only represents a partial list of companies
• the complete list has been provided in the report
View Full Report with TOC & List of Figure:
https://www.imarcgroup.com/urology-robotic-surgery-market
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
